THE merger of the Medicinal Cannabis Industry Association (MCIA) and the Emerging Therapeutics Association of Australia (ETAA) is now officially complete, bringing with it several new members to the MCIA Board.
These include Ean Alexander (CEO, Altum), Matt Cantelo (CEO, Australian Natural Therapeutics Group) and Geoff Cockerill (incoming CEO, Vitura).
Meanwhile, Chair and Director Peter Koetsier stepped down in his role at the latest Annual General Meeting.
A new Chair will be elected at the next Board meeting.
"Both Associations have made fantastic progress advancing the industry in their own right," said ETAA Chair Guy Headley when the merger was first announced in Jul this year.
"Consolidating our strengths and memberships would provide a much stronger voice for industry and a much clearer voice to stakeholders.
"On behalf of ETAA members, we are excited for what this opportunity presents for the future and further building our membership base on a strong foundation," he said.
Koetsier echoed Headley's sentiments, noting the evolution of the industry and the opportunities and challenges it now faces as it looks to grow, manufacture and supply quality products.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 24
